Search results
Results from the WOW.Com Content Network
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
Despite operating for nearly two decades without profit, 23andMe went public in 2021 and reached a $6 billion valuation. The company's stocks were priced at $11.13 a share, but they've fallen ...
At 23andMe, Wojcicki set up a lung cancer genetic study with 20 lung cancer advocacy groups, a development she announced in July. Those that know her say those losses, combined with the turmoil at ...
Meanwhile, 23andMe’s drug research (a notoriously expensive and often fruitless business) has also failed to generate significant revenue. The company is now worth less than $200 million — a ...
In March 2006 Avey, Anne Wojcicki, and Paul Cusenza founded 23andMe, [8] [9] [10] "one of the first, and only, [clarification needed] companies to offer genetic profiles directly to consumers, rather than through doctors or researchers". [11] Avey left the company in 2009. [12] Cusenza had left the company in 2007. [citation needed]
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
23andMe faces uncertainty amid acquisition talks and board resignations, and users are worried about their data. Here's what the company says.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!